Chapter 1. Research Framework

1.1. Research Objective

1.2. Product Overview

1.3. Market Segmentation

Chapter 2. Research Methodology

2.1. Qualitative Research

2.1.1. Primary & Secondary Sources

2.2. Quantitative Research

2.2.1. Primary & Secondary Sources

2.3. Breakdown of Primary Research Respondents, By Region

2.4. Assumption for the Study

2.5. Market Size Estimation

2.6. Data Triangulation

Chapter 3. Executive Summary: Global Neurostimulation Device Market

Chapter 4. Global Neurostimulation Device Market Overview

4.1. Industry Value Chain Analysis

4.1.1. Material Provider

4.1.2. Manufacturer

4.1.3. Distribution

4.1.4. End User

4.2. Industry Outlook

4.2.1. New Advancement in Neurostimulation Device

4.3. PESTLE Analysis

4.4. Porter's Five Forces Analysis

4.4.1. Bargaining Power of Suppliers

4.4.2. Bargaining Power of Buyers

4.4.3. Threat of Substitutes

4.4.4. Threat of New Entrants

4.4.5. Degree of Competition

4.5. Market Dynamics and Trends

4.5.1. Growth Drivers

4.5.2. Restraints

4.5.3. Challenges

4.5.4. Key Trends

4.6. Covid-19 Impact Assessment on Market Growth Trend

4.7. Market Growth and Outlook

4.7.1. Market Revenue Estimates and Forecast (US$ Mn), 2017 - 2030

4.7.2. Market Volume Estimates and Forecast (000' Units), 2017 - 2030

4.7.3. Price Trend Analysis, By Device Type

4.8. Competition Dashboard

4.8.1. Market Concentration Rate

4.8.2. Company Market Share Analysis (Value %), 2020

4.8.3. Competitor Mapping

Chapter 5. Neurostimulation Device Market Analysis, By Product

5.1. Key Insights

5.2. Market Size and Forecast, 2017 - 2030 (US$ Mn & 000' Units)

5.2.1. Implantable Device

5.2.1.1. Cochlear Implants (CI)

5.2.1.2. Sacral Nerve Stimulation (SNS)

5.2.1.3. Gastric Electric Stimulation (GES)

5.2.1.4. Deep Brain Stimulation (DBS)

5.2.1.5. Vagus Nerve Stimulation (VNS)

5.2.1.6. Spinal Cord Stimulation (SCS).

5.2.2. External Device

5.2.2.1. Transcranial Magnetic Stimulation (TMS)

5.2.2.2. Transcutaneous Electrical Nerve Stimulation (TENS)

Chapter 6. Neurostimulation Device Market Analysis, By Application

6.1. Key Insights

6.2. Market Size and Forecast, 2017 - 2030 (US$ Mn & 000' Units)

6.2.1. Pain Management

6.2.2. Hearing Loss

6.2.3. Urinary Incontinence

6.2.4. Parkinson's Disease

6.2.5. Epilepsy

6.2.6. Gastroparesis

6.2.7. Depression

6.2.8. Others

Chapter 7. Neurostimulation Device Market Analysis, By End User

7.1. Key Insights

7.2. Market Size and Forecast, 2017 - 2030 (US$ Mn & 000' Units)

7.2.1. Hospitals/Clinics

7.2.2. Cognitive Care Centers

7.2.3. Research Institutes

7.2.4. Others

Chapter 8. Neurostimulation Device Market Analysis, By Region

8.1. Key Insights

8.2. Market Size and Forecast, 2017 - 2030 (US$ Mn and 000' Units)

8.2.1. North America

8.2.1.1. The U.S.

8.2.1.2. Canada

8.2.1.3. Mexico

8.2.2. Europe

8.2.2.1. Western Europe

8.2.2.1.1. The UK

8.2.2.1.2. Germany

8.2.2.1.3. France

8.2.2.1.4. Italy

8.2.2.1.5. Spain

8.2.2.1.6. Rest of Western Europe

8.2.2.2. Eastern Europe

8.2.2.2.1. Poland

8.2.2.2.2. Russia

8.2.2.2.3. Rest of Eastern Europe

8.2.3. Asia Pacific

8.2.3.1. China

8.2.3.2. India

8.2.3.3. Japan

8.2.3.4. South Korea

8.2.3.5. Australia & New Zealand

8.2.3.6. ASEAN

8.2.3.7. Rest of Asia Pacific

8.2.4. Middle East & Africa

8.2.4.1. UAE

8.2.4.2. Saudi Arabia

8.2.4.3. South Africa

8.2.4.4. Rest of MEA

8.2.5. South America

8.2.5.1. Argentina

8.2.5.2. Brazil

8.2.5.3. Rest of South America

Chapter 9. North America Neurostimulation Device Market Analysis

9.1. Key Insights

9.2. Market Size and Forecast, 2017 - 2030 (US$ Mn and 000' Units)

9.2.1. By Device Type

9.2.2. By Application

9.2.3. By End User

9.2.4. By Country

Chapter 10. Europe Neurostimulation Device Market Analysis

10.1. Key Insights

10.2. Market Size and Forecast, 2017 - 2030 (US$ Mn and 000' Units)

10.2.1. By Device Type

10.2.2. By Application

10.2.3. By End User

10.2.4. By Country

Chapter 11. Asia Pacific Neurostimulation Device Market Analysis

11.1. Key Insights

11.2. Market Size and Forecast, 2017 - 2030 (US$ Mn & 000' Units)

11.2.1. By Device Type

11.2.2. By Application

11.2.3. By End User

11.2.4. By Country

Chapter 12. Middle East and Africa Neurostimulation Device Market Analysis

12.1. Key Insights

12.2. Market Size and Forecast, 2017 - 2030 (US$ Mn and 000' Units)

12.2.1. By Device Type

12.2.2. By Application

12.2.3. By End User

12.2.4. By Country

Chapter 13. South America Neurostimulation Device Market Analysis

13.1. Key Insights

13.2. Market Size and Forecast, 2017 - 2030 (US$ Mn & 000' Units)

13.2.1. By Device Type

13.2.2. By Application

13.2.3. By End User

13.2.4. By Country

Chapter 14. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)

14.1. Abbott Laboratories

14.2. Advanced Bionics

14.3. B. Braun Melsungen AG

14.4. Boston Scientific Corporation

14.5. BrainsWay

14.6. Cochlear

14.7. CONMED Corporation

14.8. KONINKLIJKE PHILIPS

14.9. Laborie Medical Technologies, Inc.

14.10. MED-EL Medical Electronics

14.11. Medtronic PLC

14.12. Nevro Corp

14.13. Zimmer Biomet Holdings, Inc.

14.14. Other Prominent Players